| Development of a peptide–drug conjugate for prostate cancer therapy W Tai, RS Shukla, B Qin, B Li, K Cheng Molecular pharmaceutics 8 (3), 901-912, 2011 | 104 | 2011 |
| Peptides used in the delivery of small noncoding RNA RS Shukla, B Qin, K Cheng Molecular pharmaceutics 11 (10), 3395-3408, 2014 | 81 | 2014 |
| Intracellular trafficking and exocytosis of a multi-component siRNA nanocomplex RS Shukla, A Jain, Z Zhao, K Cheng Nanomedicine: Nanotechnology, Biology and Medicine 12 (5), 1323-1334, 2016 | 62 | 2016 |
| Development of a biocompatible copolymer nanocomplex to deliver VEGF siRNA for triple negative breast cancer Z Zhao, Y Li, R Shukla, H Liu, A Jain, A Barve, K Cheng Theranostics 9 (15), 4508, 2019 | 44 | 2019 |
| Development of streptavidin-based nanocomplex for siRNA delivery RS Shukla, W Tai, R Mahato, W Jin, K Cheng Molecular pharmaceutics 10 (12), 4534-4545, 2013 | 29 | 2013 |
| PCBP2 siRNA reverses the alcohol-induced pro-fibrogenic effects in hepatic stellate cells RS Shukla, B Qin, YJY Wan, K Cheng Pharmaceutical research 28, 3058-3068, 2011 | 28 | 2011 |
| Identification of a LNCaP-specific binding peptide using phage display B Qin, W Tai, RS Shukla, K Cheng Pharmaceutical research 28, 2422-2434, 2011 | 28 | 2011 |
| Combined semi-empirical screening and design of experiments (DOE) approach to identify candidate formulations of a lyophilized live attenuated tetravalent viral vaccine candidate A Patel, SM Erb, L Strange, RS Shukla, OS Kumru, L Smith, P Nelson, ... Vaccine 36 (22), 3169-3179, 2018 | 26 | 2018 |
| Quantitative spectrophotometric estimation of cefadroxil using hydrotropic solubilization technique RS Shukla, A Patel, ML Soni, V Modi, YA Jaliwala Asian Journal of Pharmaceutics (AJP) 2 (3), 2008 | 26 | 2008 |
| Novel HPLC analysis of cefadroxil in bulk formulation RS Shukla, S Pandey, R Bargale Asian Journal of Pharmaceutics (AJP) 2 (2), 2008 | 19 | 2008 |
| Quantitative spectrophotometric estimation of famotidine using hydrotropic solubilization technique RK Maheshwari, RS Shukla Asian Journal of Chemistry 20 (6), 4221, 2008 | 15 | 2008 |
| Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low-and middle-income countries P Kumar, RS Shukla, A Patel, SR Pullagurla, C Bird, O Ogun, OS Kumru, ... Human Vaccines & Immunotherapeutics 17 (7), 2298-2310, 2021 | 11 | 2021 |
| Effect of formulation variables on the stability of a live, rotavirus (RV3-BB) vaccine candidate using in vitro Gastric Digestion models to mimic oral delivery P Kumar, SR Pullagurla, A Patel, RS Shukla, C Bird, OS Kumru, A Hamidi, ... Journal of Pharmaceutical Sciences 110 (2), 760-770, 2021 | 9 | 2021 |
| Novel method for spectrophotometric analysis of hydrochlorothiazide tablets using niacinamide as hydrotropic solubilizing agent RK Maheshwari, RS Shukla Asian Journal of Pharmaceutics (AJP) 2 (1), 2008 | 6 | 2008 |
| Spectrophotometric analysis of nitazoxanide in single and combined dosage form S Pandey Asian Journal of Chemistry 21 (6), 4149, 2009 | 5 | 2009 |
| Strategies of drug targeting RS Shukla, Z Chen, K Cheng Advanced Drug Delivery, 105-122, 2013 | 3 | 2013 |
| Formulation development of a stable, orally delivered live human neonatal rotavirus (rv3-bb) vaccine candidate P Kumar, S Pullagurla, RS Shukla, A Patel, C Bird, O Kumru, SB Joshi, ... | | 2018 |
| Inhibition of PCBP2 Reverses the Fibrogenic Effect of Alcohol on Hepatic Stellate Cells KC Ravi S. Shukla, Shaoying Wang Molecular Therapy 19 (May 2011), S323, 2014 | | 2014 |
| Evaluation of Therapeutic Effect of PCBP2 SiRNA on Hepatic Stellate Cells and Development of a Streptavidin-based SiRNA Delivery System RS Shukla University of Missouri-Kansas City, 2014 | | 2014 |
| Site-Specific Ocular Nucleic Acid Delivery RS Shukla, K Cheng Focal Controlled Drug Delivery, 243-262, 2013 | | 2013 |
